Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
Estudio de cinco niveles, de fase 2, abierto, de IMC-A12 administrado como único producto cada 2 semanas a pacientes con sarcoma de Ewing/TNEPP y sarcoma de tejido blando tratado anteriormente, avanzado o metastásico. A Five-Tier, Phase 2 Open-Label Study of IMC-A12 Administered as a Single Agent Every 2 Weeks in Patients With Previously-Treated, Advanced or Metastatic Soft Tissue and Ewing's Sarcoma/PNET https://kusajili.fr:443/Trial/Lq23t7OCb02I3aL7SNDxfA%24estudio-de-cinco-niveles-de-fase-2-abierto-de-imc-a12-administrado-como-unico-producto-cada-2-semanas-a-pacientes-con-sarcoma-d
I have read and accept the terms of use of the site and the Privacy Policy
Send your message